| Galectin‐3: a novel mediator of heart failure development and progression RA de Boer, AA Voors, P Muntendam, WH van Gilst, DJ van Veldhuisen European journal of heart failure 11 (9), 811-817, 2009 | 794 | 2009 |
| Exome-wide association study of plasma lipids in> 300,000 individuals DJ Liu, GM Peloso, H Yu, AS Butterworth, X Wang, A Mahajan, ... Nature genetics 49 (12), 1758-1766, 2017 | 533 | 2017 |
| Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study U Baber, R Mehran, S Sartori, MM Schoos, H Sillesen, P Muntendam, ... Journal of the American College of Cardiology 65 (11), 1065-1074, 2015 | 493 | 2015 |
| Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study H Sillesen, P Muntendam, A Adourian, R Entrekin, M Garcia, E Falk, ... JACC: Cardiovascular imaging 5 (7), 681-689, 2012 | 319 | 2012 |
| Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH AR van der Velde, L Gullestad, T Ueland, P Aukrust, Y Guo, A Adourian, ... Circulation: Heart Failure 6 (2), 219-226, 2013 | 292 | 2013 |
| Baseline and serial measurements of galectin‐3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val‐HeFT IS Anand, TS Rector, M Kuskowski, A Adourian, P Muntendam, JN Cohn European journal of heart failure 15 (5), 511-518, 2013 | 207 | 2013 |
| Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) L Gullestad, T Ueland, J Kjekshus, SH Nymo, J Hulthe, P Muntendam, ... European heart journal 33 (18), 2290-2296, 2012 | 202 | 2012 |
| Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology K Broch, T Ueland, SH Nymo, J Kjekshus, J Hulthe, P Muntendam, ... European journal of heart failure 14 (3), 268-277, 2012 | 176 | 2012 |
| The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease—study design and objectives P Muntendam, C McCall, J Sanz, E Falk, V Fuster, ... American heart journal 160 (1), 49-57. e1, 2010 | 176 | 2010 |
| A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study MB Mortensen, V Fuster, P Muntendam, R Mehran, U Baber, S Sartori, ... Journal of the American College of Cardiology 68 (9), 881-891, 2016 | 124 | 2016 |
| Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative X Yin, S Subramanian, SJ Hwang, CJ O’Donnell, CS Fox, P Courchesne, ... Arteriosclerosis, thrombosis, and vascular biology 34 (4), 939-945, 2014 | 118 | 2014 |
| The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) L Gullestad, T Ueland, J Kjekshus, SH Nymo, J Hulthe, P Muntendam, ... American heart journal 164 (6), 878-883, 2012 | 112 | 2012 |
| Galectin-3 in heart failure: high levels are associated with all-cause mortality T Ueland, P Aukrust, K Broch, S Aakhus, R Skårdal, P Muntendam, ... International journal of cardiology 150 (3), 361-364, 2011 | 106 | 2011 |
| Stromal cell–derived factor 1 as a biomarker of heart failure and mortality risk S Subramanian, C Liu, A Aviv, JE Ho, P Courchesne, P Muntendam, ... Arteriosclerosis, thrombosis, and vascular biology 34 (9), 2100-2105, 2014 | 88 | 2014 |
| Negative risk markers for cardiovascular events in the elderly MB Mortensen, V Fuster, P Muntendam, R Mehran, U Baber, S Sartori, ... Journal of the American College of Cardiology 74 (1), 1-11, 2019 | 79 | 2019 |
| Risk factors for near-term myocardial infarction in apparently healthy men and women BG Nordestgaard, AS Adourian, JJ Freiberg, Y Guo, P Muntendam, E Falk Clinical chemistry 56 (4), 559-567, 2010 | 51 | 2010 |
| Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis: The Multi-Ethnic BioImage Study P Natarajan, P Kohli, U Baber, KDH Nguyen, S Sartori, DF Reilly, ... Journal of the American College of Cardiology 66 (18), 2053-2055, 2015 | 50 | 2015 |
| Limited added value of circulating inflammatory biomarkers in chronic heart failure SH Nymo, P Aukrust, J Kjekshus, JJV McMurray, JGF Cleland, ... JACC: Heart Failure 5 (4), 256-264, 2017 | 44 | 2017 |
| Subcutaneous furosemide in heart failure: pharmacokinetic characteristics of a newly buffered solution DA Sica, P Muntendam, RL Myers, JM Ter Maaten, ME Sale, RA de Boer, ... JACC: Basic to Translational Science 3 (1), 25-34, 2018 | 41 | 2018 |
| The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population E Falk, H Sillesen, P Muntendam, V Fuster Current atherosclerosis reports 13, 359-366, 2011 | 39 | 2011 |
